The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Gut microbiome/metabolome predicts response to immune checkpoint blockers (ICB) in patients with recurrent metastatic head and neck squamous cell cancer (RM HNSCC).
 
Shahla Bari
No Relationships to Disclose
 
Shalini Jain
Stock and Other Ownership Interests - MusB
 
Hariom Yadav
Stock and Other Ownership Interests - Postbiotics Inc.
 
Min Liu
No Relationships to Disclose
 
Eli Hodge
No Relationships to Disclose
 
Kedar Kirtane
Stock and Other Ownership Interests - Agenus; Immunomedics; Macrogenics; Myovant Sciences; Oncternal Therapeutics; Seagen; Veru
 
Christine H. Chung
Consulting or Advisory Role - Exelixis; Merck; Sanofi/Regeneron
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Brooklyn ImmunoTherapeutics (Inst); Ignyta (Inst); Iovance Biotherapeutics (Inst); Lilly (Inst); Merck (Inst); Pfizer (Inst); Regeneron (Inst)
 
Jose Conejo-Garcia
Stock and Other Ownership Interests - Allogene Therapeutics; Anixa Biosciences; Compass Therapeutics
Honoraria - Allogene Therapeutics; Anixa Biosciences
Consulting or Advisory Role - Allogene Therapeutics; Anixa Biosciences; Compass Therapeutics
Research Funding - Anixa Biosciences
Patents, Royalties, Other Intellectual Property - Anixa Biosciences; Compass Therapeutics
 
Jameel Muzaffar
No Relationships to Disclose